Interventions for Persistent Pain Despite Low Inflammatory Activity in Rheumatoid Arthritis: A Systematic Review
Abstract
Persistent pain remains a significant clinical challenge in patients with rheumatoid arthritis (RA), even after achieving normal or low inflammatory activity. This discordance between inflammation control and pain relief suggests the involvement of mechanisms beyond active synovitis, yet the effectiveness of available interventions in this population has not been fully clarified. We conducted a systematic review to synthesize evidence on pharmacological and non-pharmacological interventions for persistent pain in RA patients with controlled inflammatory activity. Major biomedical databases were searched for studies reporting pain-related outcomes in adult RA patients, including randomized controlled trials, post hoc analyses of clinical trials, and prospective observational studies. Owing to heterogeneity in study design, interventions, and outcome measures, a narrative synthesis was performed. Eight studies met the inclusion criteria. Pharmacological interventions targeting inflammatory pathways, including conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic agents such as tumor necrosis factor and interleukin-6 receptor inhibitors, and targeted synthetic DMARDs such as Janus kinase inhibitors, demonstrated heterogeneous and generally limited effects on pain reduction once inflammation was controlled, with clinically meaningful pain frequently persisting despite improvements in disease activity. In contrast, non-pharmacological interventions,…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.